上海医药(02607.HK)：溴吡斯的明缓释片获得批准生产

Core Viewpoint - Shanghai Pharmaceuticals has received approval from the National Medical Products Administration for the production of Bromperidol Sustained-Release Tablets, indicating a significant advancement in its product portfolio [1] Company Summary - Shanghai Pharmaceuticals' subsidiary, Shanghai Shiyou Zhongxi Pharmaceutical Co., Ltd., has been granted a drug registration certificate (Certificate No. 2025S03175) for Bromperidol Sustained-Release Tablets, allowing the company to commence production [1]